Much remains to be understood about COVID-19, but the protective role of antibodies (Igs) is widely accepted in SARS-CoV-2 infection. Igs’ functions are mainly carried out by receptors that bind to their Fc portion (FcR), and less attention has been dedicated to the cytoplasmic members of this family. In this work, we used single-cell RNA sequencing (scRNA-seq) data to discern cell populations in bronchoalveolar lavage fluid obtained from healthy individuals and patients with mild or severe COVID-19. Then, we evaluated the transcription of neonatal FcR (FcRn, FCGRT gene) and tripartite motif-containing protein 21 (TRIM21) and its downstream signaling components. The TRIM21 pathway is vital for virus infections as it has a dual function, leading opsonized viruses to degradation by proteasomes and the activation of innate inflammatory anti-virus response. The transcriptional level of FCGRT showed no statistical differences in any cell population comparing the three groups of patients. On the other hand, TRIM21 transcription was significantly higher in myeloid cells collected from patients with mild COVID-19. When comparing mild with severe cases, there was no statistical difference in TRIM21 transcription in lung adaptive lymphoid cells and innate lymphoid cells (ILC). Yet, we analyzed the transcription of all downstream signaling molecules in myeloid and, as most cells expressed the receptor, in adaptive lymphoid cells. Moreover, ILCs from mild cases and all cell populations from severe cases were missing most downstream components of the pathway. We observed that members of the ubiquitin–proteasome system (UPS) and other components associated with TRIM21 proteasomal degradation were transcribed in mild cases. Despite the transcription of the danger sensors DDX58 and IFIH1, the transcriptional level of inflammatory IL1B and IL18 was generally very low, along with the NLRP3 danger sensor, members of the NF-κB pathway, and TNF. Therefore, our data suggest that TRIM21 may contribute to SARS-CoV-2 protection by reducing the viral load, while the inflammatory branch of the pathway would be silenced, leading to no pathogenic cytokine production.
Staphylococcus aureus is a major human pathogen responsible for a broad spectrum of infections and is recognized by the World Health Organization as a high-priority antimicrobial-resistant organism. The global transcription factor (TF) catabolite control protein A (CcpA), a central regulator of metabolism and virulence, represents a promising drug target. However, efforts to design inhibitors are hindered by their closed crystallographic conformation and the absence of well-defined ligand-binding cavities. Here, we present a structure-guided alignment strategy to identify potential ligand-binding sites in CcpA from S. aureus (Sa-CcpA), using a curated set of co-crystallized TFs as structural templates. This methodology identified a putative ligand-binding site in Sa-CcpA that was not predicted by conventional cavity-detection methods. Phylogenetic analysis showed that residues within this predicted cavity are conserved in a subset of particular pathogenic species in the order Bacillales, suggesting an evolutionarily constrained and functionally relevant region. To assess the stability of this newly identified site, multiple molecular dynamics simulations were performed, followed by docking analyses of two known Sa-CcpA inhibitors. Together, our results suggest that this structure-informed alignment strategy is a promising approach to uncover previously unrecognized ligand-binding regions in TFs. Although demonstrated here using Sa-CcpA as a case study, this approach may support future efforts to rationalize inhibitor design targeting transcriptional regulators.
After global vaccination, there was a drastic reduction in COVID-19 severe cases. However, it is important to understand what physiopathological pathways played a role in patients protection during the pandemic’s first months. Much remains to be understood about the disease, but the protective role of antibodies (Ig) is widely accepted in SARS-CoV-2 infection. Ig functions are mainly carried out by receptors that bind to their Fc portion (FcR), and less attention has been dedicated to the cytoplasmic members of this family. In this work, we used single-cell RNA sequencing (scRNAseq) data to discern cell populations present in bronchoalveolar lavage fluid obtained from healthy individuals or patients with mild or severe COVID-19. Then, we evaluated the transcription of neonatal FcR (FcRn, FCGRT gene) and tripartite motif-containing protein 21 (TRIM21) and its downstream signaling components. The TRIM21 pathway is vital for virus infections as it has a dual function, leading opsonized viruses to degradation by proteasomes and the activation of innate inflammatory anti-virus response. Our findings yielded no supporting evidence to endorse the involvement of FcRn in protecting COVID-19 patients. On the other hand, TRIM21 and related members of the via, such as members of the ubiquitin-proteasome system (UPS), were consistently upregulated in innate and adaptive lymphoid and myeloid cells from mild cases. However, despite the transcription of the danger sensors DDX58 and IFIH1, the transcriptional level of inflammatory IL1B and IL18 was generally very low, along with the NLRP3 danger sensor, members of the NF-κB pathway, and TNF. Although there were much higher numbers of cells in the samples from patients with severe symptoms, most cells transcribed near-zero levels of TRIM21. Therefore, our data suggest that TRIM21 may contribute to SARS-CoV-2 protection by reducing the viral load, while not contributing to the inflammatory branch of the pathway and pathogenic cytokine strom.